Skip to main content
68°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Eli Lilly and Co
Recent news which mentions Eli Lilly and Co
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Alphabet's new CFO was in the middle of the GLP-1 boom. Now she's onto generative AI
June 06, 2024
Tags
Internet
Technology
Morgan Stanley
From
CNBC.com News
Alphabet taps Eli Lilly's Anat Ashkenazi as new CFO
June 05, 2024
Tags
Alphabet Inc
Eli Lilly and Co
Breaking News: Technology
From
CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
May 30, 2024
Tags
Small business
Small Business: Management
Small Business
From
CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
May 29, 2024
Tags
Eli Lilly and Co
Health care industry
Novo Nordisk A/S
From
CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
May 27, 2024
Tags
Chugai Pharmaceutical Co Ltd
U/S/ Markets
Investing
From
CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
May 25, 2024
Tags
Hospitals
Eli Lilly and Co
Health care industry
From
CNBC.com News
Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply
May 24, 2024
Tags
Health care industry
Eli Lilly and Co
Business
From
CNBC.com News
Cramer's Lightning Round: Sigma Lithium is 'too dicey'
May 23, 2024
Tags
Business
Investment Strategy
Arista Networks Inc
From
CNBC.com News
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
May 23, 2024
Tags
Eli Lilly and Co
Novartis AG
Health care industry
From
CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
May 21, 2024
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Health & Science
From
CNBC.com News
Roche says weight loss drug shows promising results in early trial
May 16, 2024
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Eli Lilly and Co
From
CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
May 14, 2024
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Health & Science
From
CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
May 14, 2024
Tags
Business
Pharmaceuticals
Science
From
CNBC.com News
Google's Demis Hassabis is the man tasked with turning bleeding-edge AI research into profits
May 13, 2024
Tags
Novartis AG
Alphabet Inc
Eli Lilly and Co
From
CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
May 07, 2024
Tags
Healthy Returns
Apple Inc
Health care industry
From
CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
May 07, 2024
Tags
Zealand Pharma A/S
Health care industry
Viking Therapeutics Inc
From
CNBC.com News
Within a few years, generative AI will be designing new drugs all on its own
May 05, 2024
Tags
Drugs
AI / Artificial Intelligence
Pharmaceuticals
From
CNBC.com News
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
May 03, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Amgen Inc
From
CNBC.com News
Wegovy maker Novo Nordisk down 4%, heads for worst day since October
May 03, 2024
Tags
Europe Markets
Pharmaceuticals
LVMH Moet Hennessy Louis Vuitton SE
From
CNBC.com News
Amgen scraps experimental weight loss pill, moves forward with injection
May 02, 2024
Tags
Biotechnology
US: News
Companies
From
CNBC.com News
Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro
April 30, 2024
Tags
Biotechnology
US: News
Companies
From
CNBC.com News
5 things to know before the stock market opens Monday
April 29, 2024
Tags
5 Things to Know
Cloudflare Inc
Investing
From
CNBC.com News
Cramer's week ahead: Fed meeting and earnings from Apple, Amazon, Eli Lilly
April 26, 2024
Tags
Eli Lilly and Co
SoFi Technologies Inc
Investment strategy
From
CNBC.com News
Most people on weight loss drugs are spending less on restaurants and takeout, survey says
April 20, 2024
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Bellring Brands Inc
From
CNBC.com News
Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says
April 17, 2024
Tags
Business
Pharmaceuticals
Breaking news
From
CNBC.com News
Eli Lilly’s Zepbound shows promise as a sleep apnea treatment in late-stage trials
April 17, 2024
Tags
Breaking news
Pharmaceuticals
Business
From
CNBC.com News
EU probe of weight loss and diabetes drugs like Wegovy, Ozempic finds no link to suicidal thoughts
April 12, 2024
Tags
Companies
US: News
Biotechnology
From
CNBC.com News
Cramer says stocks that pulled back Tuesday still 'have everything going for them'
April 09, 2024
Tags
Markets
NVIDIA Corp
Investment strategy
From
CNBC.com News
Diabetes drug similar to Ozempic helped slow progression of Parkinson's disease in small trial
April 04, 2024
Tags
Eli Lilly and Co
Health care industry
Novo Nordisk A/S
From
CNBC.com News
Healthy Returns: Weight loss, diabetes drug ad spending tops $1 billion
April 03, 2024
Tags
Healthy Returns
Eli Lilly and Co
Health care industry
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.